Researchers Find Blood Pressure Medication May Treat Rare Brain Tumors

Researchers from the Chinese Academy of Sciences Institute of Genetics and Developmental Biology have discovered that a low-cost blood pressure medication may effectively treat craniopharyngioma, a rare noncancerous brain tumor located near the pituitary gland and hypothalamus, Anadolu Agency reported yesterday.

This tumor can lead to serious health issues, including hormone imbalances, vision problems, and diabetes.

Published in Science Translational Medicine, the study highlights the potential of this medication in addressing tumor growth. Lead researcher Wu Qingfeng emphasized that the findings could pave the way for future cancer drug development and enhance understanding of cell origins and gene mutations.

Currently, surgical removal is the primary treatment for craniopharyngioma, but it carries risks of complications and tumor regrowth. The research offers new insights that could inform the construction of animal models and high-throughput drug screening, ultimately contributing to more effective treatments for affected patients.